Canadian Blood Service: SARS-CoV-2 Seroprevalence Study
The main objectives of the study are to:
* monitor SARS-CoV-2 seroprevalence on a monthly basis,
* compare seroprevalence by demographic and geographic variables, and
* monitor vaccine uptake.
Overview
- Acronym
- CBS
- Website
- CBS
- Investigators
-
- Contacts
-
General Design
- Study design
- Cross-sectional
- Start - End Year
- 2020 -
- General Information on Follow Up (profile, frequency)
-
At phase I participants were seen from May 9, 2020 until July 21, 2020. As of August 2020, only samples from the last 2 weeks of each month are tested. As of December 2020, all samples are sampled once again. Additional phases of testing are anticipated.
- Recruitment Target
-
- Individuals
- Number of Participants
- No Limit
Access
Availability of data and biosamples
| Possible Access to Data | |
| Possible Access to Biosamples | |
| Other |
|
Timeline
Population
CBS population
The population consists of apparently healthy blood donors from across Canada in all larger cities and most urban areas, who are at least 17 years of age.
Selection Criteria
- Minimum age
-
17
- Countries
-
- Canada
- Canadian Provinces
-
- Alberta
- British Columbia
- Manitoba
- New Brunswick
- Newfoundland and Labrador
- Nova Scotia
- Ontario
- Prince Edward Island
- Saskatchewan
- Territory
- British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland and Labrador
- Health Status
-
- In good health
- Other Criteria
- Must meet all criteria to donate blood.
Sources of Recruitment
- Specific Population
-
- Other specific population : Blood donors
- Supplementary Information
-
Participants were regular blood donors from a combination of fixed and mobile sites in all larger cities and most urban areas. This project uses retention samples from blood donations that would normally be discarded.
Sample Size
- Number of Participants
- No Limit
Data Collection Events
| # | Name | Data sources | Data sources - Biosamples | Start | End |
|---|---|---|---|---|---|
| 0 | CBS - Phase 1 |
|
|
2020 (May) | Ongoing |
Participating Studies
| Acronym | Name | Study design | Countries |
|---|
Harmonization Initiatives Included
| Acronym | Name |
|---|
Datasets
| Name | Data Collection Events | Variables |
|---|
Areas of Information Collected
- Socio-demographic and economic characteristics
- Death
- Lifestyle and behaviours
- Physical measures and assessments
- Birth, pregnancy and reproductive health history
- Laboratory measures
- Perception of health, quality of life, development and functional limitations
- Cognition, personality and psychological measures and assessments
- Diseases
- Life events, life plans, beliefs and values
- Symptoms and signs
- Preschool, school and work life
- Medication and supplements
- Social environment and relationships
- Non-pharmacological interventions
- Physical environment
- Health and community care services utilization
- Administrative information
Variables Content Summary
Areas of Information Collected
No Areas of Information Collected
No Scales Collected
Areas of Information Collected per per Population and Data Collection Event
No Areas of Information Collected
No Scales Collected
Networks
| Acronym | Name | Harmonization Initiatives | Individual Studies |
|---|
Last Update: 2021-04-29T18:01:46.631